−0.9085USD
−45.61 MUSD
3.40 MUSD
About Renalytix plc
Sector
Industry
CEO
James Renwick McCullough
Website
Headquarters
New York
Founded
2018
ISIN
US75973T1016
FIGI
BBG00VPNC562
Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
